Vikram Thermo India [VIKRAMTH] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Vikram Thermo India Ltd.

BSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Vikram Thermo India Ltd. wins in 13 metrics, Sun Pharmaceutical Industries Ltd. wins in 7 metrics, with 0 ties. Vikram Thermo India Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Vikram Thermo India Ltd. Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) 14.06 36.73 Vikram Thermo India Ltd.
Price-to-Book Ratio 3.49 5.15 Vikram Thermo India Ltd.
Debt-to-Equity Ratio 1.59 6.68 Vikram Thermo India Ltd.
PEG Ratio 1.56 3.59 Vikram Thermo India Ltd.
EV/EBITDA 9.54 23.61 Vikram Thermo India Ltd.
Profit Margin (TTM) 27.38% 19.21% Vikram Thermo India Ltd.
Operating Margin (TTM) 42.26% 26.17% Vikram Thermo India Ltd.
EBITDA Margin (TTM) 42.26% 26.17% Vikram Thermo India Ltd.
Return on Equity 6.67% 15.08% Sun Pharmaceutical Industries Ltd.
Return on Assets (TTM) 5.55% 11.87% Sun Pharmaceutical Industries Ltd.
Free Cash Flow (TTM) $-171.83M $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield 1.03% 0.97% Vikram Thermo India Ltd.
1-Year Return 15.09% 7.10% Vikram Thermo India Ltd.
Price-to-Sales Ratio (TTM) 3.85 7.05 Vikram Thermo India Ltd.
Enterprise Value $4.69B $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 3.78 6.66 Vikram Thermo India Ltd.
Gross Profit Margin (TTM) 68.12% 80.96% Sun Pharmaceutical Industries Ltd.
Revenue per Share (TTM) $40 $237 Sun Pharmaceutical Industries Ltd.
Earnings per Share (Diluted) $10.86 $45.46 Sun Pharmaceutical Industries Ltd.
Beta (Stock Volatility) -0.17 0.11 Vikram Thermo India Ltd.

Vikram Thermo India Ltd. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

VIKRAMTH
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Vikram Thermo India Ltd.0.42%-0.74%27.11%32.24%17.53%19.64%
Sun Pharmaceutical Industries Ltd.-0.09%0.96%-3.84%1.28%0.50%4.93%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Vikram Thermo India Ltd.15.09%128.85%10.31%159.92%667.33%667.33%
Sun Pharmaceutical Industries Ltd.7.10%82.23%170.41%143.23%656.74%2,541.29%

Performance & Financial Health Analysis: Vikram Thermo India Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricVIKRAMTHSUNPHARMA
Market Information
Market Cap i₹4.79B₹3.88T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i7,3583,903,142
90 Day Avg. Volume i7,0133,253,866
Last Close₹193.40₹1,806.00
52 Week Range₹126.85 - ₹216.50₹1,548.00 - ₹1,916.60
% from 52W High-10.67%-5.77%
All-Time High₹311.00 (Apr 25, 2022)₹1,960.35 (Sep 30, 2024)
% from All-Time High-37.81%-7.87%
Growth Metrics
Quarterly Revenue Growth-0.01%0.14%
Quarterly Earnings Growth0.09%0.16%
Financial Health
Profit Margin (TTM) i0.27%0.19%
Operating Margin (TTM) i0.42%0.26%
Return on Equity (TTM) i0.07%0.15%
Debt to Equity (MRQ) i1.596.68
Cash & Liquidity
Book Value per Share (MRQ)₹43.76₹324.46
Cash per Share (MRQ)₹3.51₹115.87
Operating Cash Flow (TTM) i₹325.14M₹110.84B
Levered Free Cash Flow (TTM) i₹80.99M₹109.29B
Dividends
Last 12-Month Dividend Yield i1.03%0.97%
Last 12-Month Dividend i₹1.75₹16.50

Valuation & Enterprise Metrics Analysis: Vikram Thermo India Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricVIKRAMTH (Apr 26, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i14.0636.73
Forward P/E iN/A29.48
PEG Ratio i1.563.59
Price to Sales (TTM) i3.857.05
Price to Book (MRQ) i3.495.15
Market Capitalization
Market Capitalization i₹4.79B₹3.88T
Enterprise Value i₹4.69B₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i3.786.66
Enterprise to EBITDA i9.5423.61
Risk & Other Metrics
Beta i-0.170.11
Book Value per Share (MRQ) i₹43.76₹324.46

Financial Statements Comparison: Vikram Thermo India Ltd. vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricVIKRAMTH (2025)SUNPHARMA (2025)
Revenue/Sales i1.25B520.41B
Cost of Goods Sold i554.93M121.98B
COGS % of Revenue i44.4%23.4%
Gross Profit i694.42M398.44B
Gross Margin i55.6%76.6%
Research & Development iN/AN/A
Operating Income (EBIT) i433.39M125.81B
Operating Margin i34.7%24.2%
EBITDA i462.90M167.25B
EBITDA Margin i37.1%32.1%
Pre-Tax Income i441.36M137.52B
Pre-Tax Income % of Revenue i35.3%26.4%
Income Tax i103.77M27.72B
Income Tax % of Revenue i8.3%5.3%
Net Income (Profit) i80.99M109.65B
Profit Margin i6.5%21.1%

Balance Sheet & Liquidity Metrics

MetricVIKRAMTH (2025)SUNPHARMA (2025)
Cash & Equivalents i1.62M102.69B
Total Current Assets i627.63M526.24B
Total Current Assets % of Revenue i50.2%101.1%
Total Current Liabilities i200.68M181.94B
Total Current Liabilities % of Revenue i16.1%35.0%
Long-Term Debt i21.88M3.58B
Long-Term Debt % of Revenue i1.8%0.7%
Total Shareholders Equity i1.21B724.86B
Retained Earnings i806.21M578.62B
Retained Earnings % of Revenue i64.5%111.2%
Property, Plant & Equipment i27.49M100.36B

Cash Flow Statement Comparison

MetricVIKRAMTH (2025)SUNPHARMA (2025)
Operating Cash Flow i325.14M110.84B
Operating Cash Flow % of Revenue i26.0%21.3%
Capital Expenditures i-395.52M-20.68B
Free Cash Flow i-171.83M119.44B
FCF Margin i-13.8%23.0%
Debt Repayment i-23.32M-43.44B
Common Stock Repurchase iN/A-29.00B

Short Interest & Institutional Ownership Analysis

MetricVIKRAMTHSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i31.36M2.40B
Float Shares i9.21M1.07B
% Held by Insiders i69.51%55.62%
% Held by Institutions i0.00%28.69%
% Held by Public i30.49%15.69%

Dividend Analysis & Yield Comparison: Vikram Thermo India Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricVIKRAMTHSUNPHARMA
Last 12-Month Dividend i₹1.75₹16.50
Last 12-Month Dividend Yield i1.03%0.97%
3-Year Avg Annual Dividend i₹0.75₹17.33
3-Year Avg Dividend Yield i0.50%0.51%
3-Year Total Dividends i₹2.25₹52.00
Ex-Dividend DateSep 19, 2025Feb 05, 2026